Recent evidence showed that SPOCK1 overexpression was observed in several cancer types, such as prostate [15], colorectal [16], gastric [17], pancreatic [18], and lung [19] cancers, and it was involved in modulating cancer cell proliferation, apoptosis, metastasis, and drug resistance. The gene discussed is SPOCK1; the disease is cancer.